Search
Kalvista Pharmaceuticals Inc
KALVAdd to Watchlist
26.990USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.44BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-10The current earnings forecast score of Kalvista Pharmaceuticals Inc is 6.57, ranking 328 out of 390 in the Biotechnology & Medical Research industry. The average price target is 30.00, with a high of 39.00 and a low of 22.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Kalvista Pharmaceuticals Inc's expected revenue for the next quarter?
Kalvista Pharmaceuticals Inc's expected revenue is 13.08M.
What is Kalvista Pharmaceuticals Inc's price target?
Analysts forecast that Kalvista Pharmaceuticals Inc's price target is USD 30.00, with the highest forecast at USD 39.00 and the lowest forecast at USD 22.00.
How have Kalvista Pharmaceuticals IncKALV's recent earnings per share performed?
The market expectation was USD -0.43, while Kalvista Pharmaceuticals IncKALV's earnings per share (EPS) for the previous quarter was USD -1.12. EPS for the next quarter is expected at USD -0.23.
